Table 1. Demographic characteristics and comorbidities of patients pre-BPA and post-BPA.
BPA: Best practice advisory
p < 0.05 was considered statistically significant
Pre-BPA | Post-BPA | p-value | |
Total: 447 patients | 178 | 269 | <1.000 |
Age | |||
18-34 years | 3 | 1 | <0.3519 |
35-49 years | 2 | 6 | <0.6172 |
50-64 years | 29 | 47 | <0.8442 |
65-79 years | 78 | 110 | <0.6058 |
>80 years | 66 | 105 | <0.7513 |
Male | 102 | 168 | <0.3216 |
Female | 76 | 101 | <0.3216 |
Race | |||
White | 168 | 244 | <0.2163 |
Black | 0 | 0 | <1.000 |
Hispanic | 0 | 0 | <1.000 |
Asian | 1 | 0 | <0.3982 |
Other | 9 | 25 | <0.1409 |
Ethnicity | |||
Not Hispanic, Latino/a, or Spanish origin | 176 | 258 | <0.1237 |
Hispanic, Latino/a, or Spanish origin | 2 | 5 | <0.8229 |
Hispanic or Latino/a | 0 | 0 | <1.000 |
Declined to answer | 0 | 0 | <1.000 |
Other | 0 | 6 | <0.0855 |
Comorbidities | |||
Coronary artery disease | 102 | 149 | <0.6898 |
Congestive heart failure | 141 | 216 | <0.7799 |
Hypertension | 89 | 133 | <0.9081 |
Diabetes mellitus type 2 | 86 | 133 | <0.8154 |